BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC

To explore the role of genetic polymorphisms of bone morphogenic proteins 4 (BMP-4) in the response to platinum-based chemotherapy and the clinical outcome in patients with advanced nonsmall cell lung cancer (NSCLC), 938 patients with stage III (A+B) or IV NSCLC were enrolled in this study. We found...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Sun, Jilu, Lang, Zhennan, Tian, Yang, Zhou, Yang, Hu, Jingshu, Geng, Songbin, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977566/
https://www.ncbi.nlm.nih.gov/pubmed/24779016
http://dx.doi.org/10.1155/2014/801640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977566/
https://www.ncbi.nlm.nih.gov/pubmed/24779016
http://dx.doi.org/10.1155/2014/801640

Ejemplares similares